See today's BioWorld Asia
To read the full story, subscribe or sign in.

Rznomics raises ₩37.2B in series C round

June 14, 2022
By David Ho
Rznomics Inc. recently secured ₩37.2 billion (US$30 million) from private investors and the Korean government in a series C financing round.
BioWorld Asia Financings Gene therapy Series C Asia-Pacific